Search research articles
Contact Us
Filters
Showing results (401-410 of 448) with videos related to
Page
of 45
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 9, 2022
RADICALS-HD: Reflections before the Results are Known
C C Parker, N W Clarke, C Catton, et al.
Emerging Microbes & Infections
|
August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical disease
Declan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.
Physical Review Letters
|
September 26, 2015
Generation of electromagnetic fields of extremely high intensity by coherent summation of Cherenkov superradiance pulses
N S Ginzburg, A W Cross, A A Golovanov, et al.
Biorxiv : the Preprint Server for Biology
|
June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine
Jacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Cell Reports
|
September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
Michael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Science Translational Medicine
|
December 14, 2022
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
Ruth Hunegnaw, Anna N Honko, Lingshu Wang, et al.
Cell
|
October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodies
Pavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
JCI Insight
|
April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
Robert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine
|
April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates
Larry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Journal of Virology
|
June 10, 2025
Monotherapy with antibody 1C3 partially protects Ebola virus-exposed macaques
Gabriella Worwa, Carl W Davis, Sarah E Klim, et al.
Page
of 45
Search research articles
Search
Showing results (401-410 of 448) with videos related to
Sort By:
Page
of 45
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 9, 2022
RADICALS-HD: Reflections before the Results are Known
C C Parker, N W Clarke, C Catton, et al.
Emerging Microbes & Infections
|
August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical disease
Declan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.
Physical Review Letters
|
September 26, 2015
Generation of electromagnetic fields of extremely high intensity by coherent summation of Cherenkov superradiance pulses
N S Ginzburg, A W Cross, A A Golovanov, et al.
Biorxiv : the Preprint Server for Biology
|
June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine
Jacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Cell Reports
|
September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
Michael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Science Translational Medicine
|
December 14, 2022
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
Ruth Hunegnaw, Anna N Honko, Lingshu Wang, et al.
Cell
|
October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodies
Pavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
JCI Insight
|
April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
Robert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine
|
April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates
Larry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Journal of Virology
|
June 10, 2025
Monotherapy with antibody 1C3 partially protects Ebola virus-exposed macaques
Gabriella Worwa, Carl W Davis, Sarah E Klim, et al.
Page
of 45